Drug Trial Radar · NCT02477800
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Last checked: Nov 20, 2026Latest source record: Sep 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,653
Actual
Start
Aug 13, 2015
Primary completion
Aug 8, 2019
Study completion Aug 8, 2019
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Jun 23, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the effect of monthly doses of aducanumab as compared with placebo on clinical progression as measured by Mini-Mental State Examination (MMSE), AD Assessment Scale-Cognitive Subscale (13 items) \[ADAS-Cog 13\], and AD Cooperative Study-Activities of Daily Living Inventory (Mild Cognitive Impairment version) \[ADCS-ADL-MCI\].
Conditions
- Alzheimer's Disease
Interventions
Aducanumab (BIIB037)Drug
Low dose
Aducanumab (BIIB037)Drug
High dose
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Clinical Dementia Rating Sum of Boxes (CDR-SB) Score at Week 78Time frame: Baseline, Week 78
Locations
181 sites in 14 countries. Site status is shown where the registry gives one.
St. Joseph's Hospital and Medical Center
Phoenix, Arizona
Center for Neurosciences
Tucson, Arizona
Neurology Center of North Orange County
Fullerton, California
Senior Clinical Trials, Inc.
Laguna Hills, California
Torrance Clinical Research Institute, Inc.
Lomita, California
University of California - Los Angeles
Los Angeles, California
UCSF - Memory and Aging Center
San Francisco, California
California Neuroscience Research Medical Group Inc.
Sherman Oaks, California
Southern California Research LLC
Simi Valley, California
Institute for Neurodegenerative Disorders
New Haven, Connecticut
Georgetown University Hospital
Washington D.C., District of Columbia
Brain Matters Research, Inc.
Delray Beach, Florida
Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
University of Miami
Miami, Florida
Miami Jewish Health Systems
Miami, Florida
Compass Research Main
Orlando, Florida
Palm Beach Neurological Center
Palm Beach Gardens, Florida
Stedman Clinical Trials, LLC
Tampa, Florida
USF Health Byrd Institute
Tampa, Florida
Meridien Research
Tampa, Florida
Compass Research Main
The Villages, Florida
Premiere Research Institute
West Palm Beach, Florida
Cleveland Clinic Florida - Weston
Weston, Florida
Alexian Brothers Neurosciences Institute
Elk Grove Village, Illinois
Advocate Lutheran General Hospital
Park Ridge, Illinois
Fort Wayne Neurological Center
Fort Wayne, Indiana
Indiana University School of Medicine
Indianapolis, Indiana
University of Kansas Medical Center Research Institute, Inc.
Kansas City, Kansas
Via Christi Research, a division of Via Christi Hospitals Wichita, Inc.
Wichita, Kansas
Baptist Health Lexington
Lexington, Kentucky
Brigham & Women's Hosp End/Dbt
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
ActivMed Practices & Research
Methuen, Massachusetts
Donald S. Marks, M.D., P.C.
Plymouth, Massachusetts
Mayo Clinic
Rochester, Minnesota
Washington University
St Louis, Missouri
Las Vegas Medical research
Las Vegas, Nevada
Advanced Memory Research Institute of NJ, PC
Toms River, New Jersey
Albany Medical College
Albany, New York
Showing 40 of 181 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.